Eli Lilly said that a new drug combination helps diabetics lose up to 23% of weight, higher than other drugs in similar studies, indicating that it may be Eli Lilly's strongest weight loss treatment to date. Eli Lilly combined an ongoing compound called eloralintide with its blockbuster drug Mounjaro. Eloralintide mimics the mechanism of action of the intestinal hormone insulin in the body. Patients receiving the highest dose combination lost an average of 54 pounds and reduced glycated hemoglobin by 2.9%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.